The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

Friday initiated legal action against the three largest prescription drug benefit managers (PBMs) in the U.S.—Caremark Rx, ...

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say made insulin prices soar.

And lest the wanna-be bullies of public relations (like those called out in a 2021 Mother Jones’ barnburner Amazon exposé) ...

LinkedIn suspends AI training with UK user data after ICO intervention. Tech giants face scrutiny over data privacy in AI ...

A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...

A new Federal Trade Commission staff report says major social media and video streaming services conducted vast surveillance ...

The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...

U.S. Federal Trade Commission Chair Lina Khan on Friday welcomed that companies are weighing antitrust considerations early ...